Search filters

List of works by Sarah A Marshall

Abnormal extracellular matrix remodelling in the cervix of pregnant relaxin-deficient mice is not associated with reduced matrix metalloproteinase expression or activity.

scientific article published on 14 March 2018

Animal models of preeclampsia: translational failings and why.

scientific article

B7-33 replicates the vasoprotective functions of human relaxin-2 (serelaxin).

scientific article published on 3 May 2017

Corrigendum to "Sulforaphane improves syncytiotrophoblast mitochondrial function after in vitro hypoxic and superoxide injury" [Placenta 96 (2020) 44-54]

scientific article published on 22 August 2020

Current and emerging pharmacotherapy for emergency management of preeclampsia

scientific article published in February 2019

Evidence of proteinuria, but no other characteristics of pre-eclampsia, in relaxin-deficient mice.

scientific article published on 4 August 2016

From pregnancy to cardiovascular disease: Lessons from relaxin-deficient animals to understand relaxin actions in the vascular system

scientific article published on 10 July 2018

Measuring Sulforaphane and Its Metabolites in Human Plasma: A High Throughput Method

scientific article published on 13 February 2020

Prolong: a double-blind randomised placebo-controlled trial of broccoli sprout extract in women with early onset preeclampsia. A clinical trial protocol

scientific article published on 17 October 2019

Relaxin Deficiency Leads to Uterine Artery Dysfunction During Pregnancy in Mice.

scientific article published on 22 March 2018

Relaxin deficiency attenuates pregnancy-induced adaptation of the mesenteric artery to angiotensin II in mice.

scientific article published on 2 March 2016

Relaxin deficiency results in increased expression of angiogenesis- and remodelling-related genes in the uterus of early pregnant mice but does not affect endometrial angiogenesis prior to implantation

scientific article published on 22 March 2016

Relaxin reduces endothelium-derived vasoconstriction in hypertension: Revealing new therapeutic insights

scientific article published on 31 October 2019

Relaxin treatment reduces angiotensin II-induced vasoconstriction in pregnancy and protects against endothelial dysfunction†.

scientific article published on 3 April 2017

Resveratrol mitigates trophoblast and endothelial dysfunction partly via activation of nuclear factor erythroid 2-related factor-2.

scientific article published on 8 November 2017

Serelaxin Treatment Reduces Oxidative Stress and Increases Aldehyde Dehydrogenase-2 to Attenuate Nitrate Tolerance.

scientific article published on 21 March 2017

Short-term (48 hours) intravenous serelaxin infusion has no effect on myogenic tone or vascular remodeling in rat mesenteric arteries

scientific article published on 31 March 2017

Sulforaphane improves endothelial function and reduces placental oxidative stress in vitro

scientific article published in April 2019

Sulforaphane improves syncytiotrophoblast mitochondrial function after in vitro hypoxic and superoxide injury

scientific article published on 19 May 2020

Sulforaphane improves vascular reactivity in mouse and human arteries after "preeclamptic-like" injury

scientific article published on 02 September 2020

Targeting the vascular dysfunction: Potential treatments for preeclampsia

scientific article published on 16 December 2018

The Novel Small-molecule Annexin-A1 Mimetic, Compound 17b, Elicits Vasoprotective Actions in Streptozotocin-induced Diabetic Mice

scientific article published on 18 February 2020

The Role of Relaxin in Normal and Abnormal Uterine Function During the Menstrual Cycle and Early Pregnancy.

scientific article published on 29 June 2016

The peptide hormone relaxin: from bench to bedside.

scientific article published on 7 February 2018

Vascular actions of relaxin: nitric oxide and beyond

scientific article published on 30 September 2016